| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.65▼ | 7.65▼ | 7.70▼ | 7.50▲ | 7.30▲ |
| MA10 | 7.64▼ | 7.71▼ | 7.60▲ | 7.25▲ | 7.68▼ |
| MA20 | 7.64▼ | 7.60▲ | 7.61▲ | 7.20▲ | 9.29▼ |
| MA50 | 7.70▼ | 7.59▲ | 7.44▲ | 7.80▼ | 9.70▼ |
| MA100 | 7.62▲ | 7.40▲ | 7.21▲ | 9.37▼ | 9.22▼ |
| MA200 | 7.60▲ | 7.20▲ | 7.35▲ | 9.00▼ | 12.94▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.004▼ | -0.003▼ | 0.121▲ | -0.210▼ |
| RSI | 45.889▼ | 50.660▲ | 53.031▲ | 52.488▲ | 44.829▼ |
| STOCH | 70.556 | 42.146 | 77.131 | 73.996 | 16.222▼ |
| WILL %R | -50.000 | -44.340 | -33.813 | -22.646▲ | -79.340▼ |
| CCI | -80.128 | -31.591 | 44.404 | 100.791▲ | -56.289 |
|
Thursday, November 05, 2026 04:05 AM
PRNewswire/ -- (Nasdaq: RGNX) today reported financial results and operational highlights for the third quarter ended September 30, 2026.
|
|
Tuesday, August 25, 2026 08:07 AM
REGENXBIO RGNX stock plunged 24.9% on Monday after the FDA placed a clinical hold on its investigational one-time gene therapy, RGX-121, for the treatment of boys with Mucopolysaccharidosis Type II ...
|
|
Monday, August 24, 2026 05:45 AM
REGENXBIO Inc. (NASDAQ:RGNX) shares tumbled 35% after the U.S. Food and Drug Administration placed a clinical hold on RGX-121, the company’s investigational gene therapy for Mucopolysaccharidosis type ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 7.33 | 7.87 | 7.33 | 7.62 | 1,186,481 |
| 05/11/26 | 7.20 | 7.68 | 7.15 | 7.38 | 1,677,167 |
| 04/11/26 | 7.72 | 7.96 | 7.475 | 7.71 | 1,135,229 |
| 03/11/26 | 7.29 | 7.645 | 7.266 | 7.63 | 854,905 |
| 02/11/26 | 7.27 | 7.4586 | 7.04 | 7.16 | 1,029,332 |
| 30/10/26 | 7.38 | 7.535 | 7.00 | 7.20 | 1,061,620 |
| 29/10/26 | 7.36 | 7.63 | 7.21 | 7.41 | 1,033,249 |
| 28/10/26 | 6.52 | 7.285 | 6.505 | 7.24 | 1,997,383 |
| 27/10/26 | 6.54 | 6.78 | 6.4586 | 6.60 | 1,219,377 |
| 26/10/26 | 6.74 | 6.89 | 6.48 | 6.58 | 1,137,663 |
|
|
||||
|
|
||||
|
|